- Future Students
- DVM degree program
- Graduate Programs
- Request information
- Contacts, Map, and Directions
- Current Students
- Faculty & Staff
Filters: Keyword is Anti-Bacterial Agents [Clear All Filters]
Bermudez LE, Motamedi N, Chee C, Baimukanova G, Kolonoski P, Inderlied C, Aralar P, Wang G, Phan LT, Young LS. 2007. EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 51(5):1666-70.
Bermudez LE, Inderlied CB, Kolonoski P, Wu M, Aralar P, Young LS. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.. Antimicrobial agents and chemotherapy. 45(8):2210-4.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.
Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, Young LS. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 45(1):217-22.